NZ706019A - Improved methods for the acylation of maytansinol - Google Patents
Improved methods for the acylation of maytansinolInfo
- Publication number
- NZ706019A NZ706019A NZ706019A NZ70601913A NZ706019A NZ 706019 A NZ706019 A NZ 706019A NZ 706019 A NZ706019 A NZ 706019A NZ 70601913 A NZ70601913 A NZ 70601913A NZ 706019 A NZ706019 A NZ 706019A
- Authority
- NZ
- New Zealand
- Prior art keywords
- maytansinol
- acylation
- improved methods
- amino acid
- carboxyanhydride
- Prior art date
Links
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
- H01R12/00—Structural associations of a plurality of mutually-insulated electrical connecting elements, specially adapted for printed circuits, e.g. printed circuit boards [PCB], flat or ribbon cables, or like generally planar structures, e.g. terminal strips, terminal blocks; Coupling devices specially adapted for printed circuits, flat or ribbon cables, or like generally planar structures; Terminals specially adapted for contact with, or insertion into, printed circuits, flat or ribbon cables, or like generally planar structures
- H01R12/50—Fixed connections
- H01R12/51—Fixed connections for rigid printed circuits or like structures
- H01R12/55—Fixed connections for rigid printed circuits or like structures characterised by the terminals
- H01R12/58—Fixed connections for rigid printed circuits or like structures characterised by the terminals terminals for insertion into holes
- H01R12/585—Terminals having a press fit or a compliant portion and a shank passing through a hole in the printed circuit board
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K1/00—Printed circuits
- H05K1/02—Details
- H05K1/0201—Thermal arrangements, e.g. for cooling, heating or preventing overheating
- H05K1/0203—Cooling of mounted components
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K1/00—Printed circuits
- H05K1/02—Details
- H05K1/11—Printed elements for providing electric connections to or between printed circuits
- H05K1/115—Via connections; Lands around holes or via connections
- H05K1/116—Lands, clearance holes or other lay-out details concerning the surrounding of a via
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
- H05K1/00—Printed circuits
- H05K1/18—Printed circuits structurally associated with non-printed electric components
- H05K1/181—Printed circuits structurally associated with non-printed electric components associated with surface mounted components
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polyamides (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ73957313A NZ739573A (en) | 2012-09-26 | 2013-09-26 | Improved methods for the acylation of maytansinol |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261705731P | 2012-09-26 | 2012-09-26 | |
| PCT/US2013/061839 WO2014052537A1 (en) | 2012-09-26 | 2013-09-26 | Improved methods for the acylation of maytansinol |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ706019A true NZ706019A (en) | 2018-03-23 |
Family
ID=49328648
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ706019A NZ706019A (en) | 2012-09-26 | 2013-09-26 | Improved methods for the acylation of maytansinol |
| NZ73957313A NZ739573A (en) | 2012-09-26 | 2013-09-26 | Improved methods for the acylation of maytansinol |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ73957313A NZ739573A (en) | 2012-09-26 | 2013-09-26 | Improved methods for the acylation of maytansinol |
Country Status (27)
| Country | Link |
|---|---|
| US (9) | US9012629B2 (enExample) |
| EP (3) | EP3904358A1 (enExample) |
| JP (7) | JP6517693B2 (enExample) |
| CN (2) | CN104768955B (enExample) |
| AU (4) | AU2013323572B2 (enExample) |
| BR (2) | BR122021022582B1 (enExample) |
| CA (2) | CA3133906C (enExample) |
| CY (2) | CY1121415T1 (enExample) |
| DK (2) | DK2900676T3 (enExample) |
| ES (2) | ES2880754T3 (enExample) |
| HR (2) | HRP20190473T1 (enExample) |
| HU (2) | HUE055443T2 (enExample) |
| IL (2) | IL237899A (enExample) |
| LT (2) | LT2900676T (enExample) |
| MX (2) | MX366701B (enExample) |
| MY (1) | MY169250A (enExample) |
| NZ (2) | NZ706019A (enExample) |
| PL (2) | PL2900676T3 (enExample) |
| PT (2) | PT3486248T (enExample) |
| RS (2) | RS62075B1 (enExample) |
| RU (2) | RU2765072C2 (enExample) |
| SG (1) | SG11201501918UA (enExample) |
| SI (2) | SI2900676T1 (enExample) |
| SM (2) | SMT202100390T1 (enExample) |
| TR (1) | TR201903625T4 (enExample) |
| WO (1) | WO2014052537A1 (enExample) |
| ZA (1) | ZA201501898B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT2900676T (lt) * | 2012-09-26 | 2019-03-25 | Immunogen, Inc. | Maitanzinolio acilinimo patobulintas būdas |
| CN105585579A (zh) * | 2014-10-24 | 2016-05-18 | 南京联宁生物制药有限公司 | 一种化合物及其制备方法以及美登素dm1的制备方法 |
| AU2016233227B2 (en) | 2015-03-17 | 2020-03-12 | Regeneron Pharmaceuticals, Inc. | Amino acid acylation reagents and methods of using the same |
| CN110234348B (zh) | 2016-12-16 | 2024-06-25 | 蓝鳍生物医药公司 | 抗-含cub结构域蛋白1(cdcp1)抗体、抗体药物缀合物及其使用方法 |
| SI3956332T1 (sl) | 2019-04-18 | 2023-05-31 | Indena S.P.A. | Diasteroselektivni postopek za pripravo tiol- ali disulfid-vsebujočih majtansinoidnih estrov in njihovih intermediatov |
| EP4067497A4 (en) | 2019-11-29 | 2024-03-13 | MicroBiopharm Japan Co., Ltd. | Method for enzymatically producing maytansinol |
| WO2024225377A1 (ja) | 2023-04-28 | 2024-10-31 | 中外製薬株式会社 | Ｎ－カルボキシアミノ酸無水物を用いたアミド基含有化合物の製造方法 |
Family Cites Families (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4151042A (en) | 1977-03-31 | 1979-04-24 | Takeda Chemical Industries, Ltd. | Method for producing maytansinol and its derivatives |
| JPS6034556B2 (ja) * | 1977-03-31 | 1985-08-09 | 武田薬品工業株式会社 | 抗生物質ｃ−１５００３ |
| US4137230A (en) | 1977-11-14 | 1979-01-30 | Takeda Chemical Industries, Ltd. | Method for the production of maytansinoids |
| US4265814A (en) | 1978-03-24 | 1981-05-05 | Takeda Chemical Industries | Matansinol 3-n-hexadecanoate |
| JPS5562090A (en) | 1978-10-27 | 1980-05-10 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| JPS5566585A (en) | 1978-11-14 | 1980-05-20 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| JPS55164687A (en) | 1979-06-11 | 1980-12-22 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| JPS55162791A (en) | 1979-06-05 | 1980-12-18 | Takeda Chem Ind Ltd | Antibiotic c-15003pnd and its preparation |
| JPS55164685A (en) | 1979-06-08 | 1980-12-22 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| JPS55164686A (en) | 1979-06-11 | 1980-12-22 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| US4309428A (en) | 1979-07-30 | 1982-01-05 | Takeda Chemical Industries, Ltd. | Maytansinoids |
| JPS5622790A (en) * | 1979-07-31 | 1981-03-03 | Takeda Chem Ind Ltd | Novel maytansinoid compound and its preparation |
| JPS5645483A (en) | 1979-09-19 | 1981-04-25 | Takeda Chem Ind Ltd | C-15003phm and its preparation |
| JP3054741B2 (ja) * | 1989-09-29 | 2000-06-19 | 武田薬品工業株式会社 | Ｔａｎ―１３１３およびそのアシル誘導体 |
| US5208020A (en) | 1989-10-25 | 1993-05-04 | Immunogen Inc. | Cytotoxic agents comprising maytansinoids and their therapeutic use |
| HK1049787B (en) * | 1999-10-01 | 2014-07-25 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
| US6441163B1 (en) | 2001-05-31 | 2002-08-27 | Immunogen, Inc. | Methods for preparation of cytotoxic conjugates of maytansinoids and cell binding agents |
| TWI298067B (en) * | 2002-01-31 | 2008-06-21 | Daiso Co Ltd | New optically active compound, method for kinetic resolution of carbonic acid derivatives and catalyst thereof |
| US8088387B2 (en) | 2003-10-10 | 2012-01-03 | Immunogen Inc. | Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates |
| CR20170291A (es) * | 2003-05-20 | 2017-07-27 | Immunogen Inc | Agentes citotoxicos mejorados que comprenden nuevos maitansinóides |
| KR20070029616A (ko) * | 2003-08-22 | 2007-03-14 | 액티브 바이오틱스 인코포레이티드 | 리파마이신 유사체 및 그의 용도 |
| CN101065151B (zh) | 2004-09-23 | 2014-12-10 | 健泰科生物技术公司 | 半胱氨酸改造的抗体和偶联物 |
| WO2006062779A2 (en) | 2004-12-09 | 2006-06-15 | Centocor, Inc. | Anti-integrin immunoconjugates, methods and uses |
| US7301019B2 (en) * | 2005-01-21 | 2007-11-27 | Immunogen, Inc. | Method for the preparation of maytansinoid esters |
| WO2007011721A1 (en) * | 2005-07-15 | 2007-01-25 | Kalypsys, Inc. | Inhibitors of mitotic kinesin |
| CA2617953C (en) * | 2005-08-09 | 2013-12-17 | Millennium Pharmaceuticals, Inc. | Method of acylating maytansinol with chiral amino acids |
| CA2668134A1 (en) * | 2006-11-06 | 2008-05-15 | Teva Gyogyszergyar Zartkoerueen Muekoedoe Reszvenytarsasag | Ascomycin and pimecrolimus having reduced levels of des-methylascomycin and 32-deoxy-32-epichloro-desmethylascomycin respectively, and methods for preparation thereof |
| JP2008288289A (ja) | 2007-05-16 | 2008-11-27 | Oki Electric Ind Co Ltd | 電界効果トランジスタとその製造方法 |
| IL300840A (en) | 2009-06-03 | 2023-04-01 | Immunogen Inc | coupling methods |
| US8754207B2 (en) * | 2009-09-25 | 2014-06-17 | Cadila Healthcare Limited | Process for the preparation of rapamycin derivatives |
| CA2816426A1 (en) * | 2010-11-17 | 2012-06-07 | Genentech, Inc. | Alaninyl maytansinol antibody conjugates |
| LT2900676T (lt) | 2012-09-26 | 2019-03-25 | Immunogen, Inc. | Maitanzinolio acilinimo patobulintas būdas |
-
2013
- 2013-09-26 LT LTEP13774881.0T patent/LT2900676T/lt unknown
- 2013-09-26 SM SM20210390T patent/SMT202100390T1/it unknown
- 2013-09-26 EP EP21166484.2A patent/EP3904358A1/en active Pending
- 2013-09-26 AU AU2013323572A patent/AU2013323572B2/en active Active
- 2013-09-26 DK DK13774881.0T patent/DK2900676T3/en active
- 2013-09-26 CA CA3133906A patent/CA3133906C/en active Active
- 2013-09-26 HU HUE18213678A patent/HUE055443T2/hu unknown
- 2013-09-26 TR TR2019/03625T patent/TR201903625T4/tr unknown
- 2013-09-26 BR BR122021022582-6A patent/BR122021022582B1/pt active IP Right Grant
- 2013-09-26 CN CN201380049853.8A patent/CN104768955B/zh active Active
- 2013-09-26 US US14/037,657 patent/US9012629B2/en active Active
- 2013-09-26 HU HUE13774881A patent/HUE043285T2/hu unknown
- 2013-09-26 PT PT182136788T patent/PT3486248T/pt unknown
- 2013-09-26 ES ES18213678T patent/ES2880754T3/es active Active
- 2013-09-26 NZ NZ706019A patent/NZ706019A/en unknown
- 2013-09-26 CA CA2884873A patent/CA2884873C/en active Active
- 2013-09-26 MY MYPI2015000663A patent/MY169250A/en unknown
- 2013-09-26 NZ NZ73957313A patent/NZ739573A/en unknown
- 2013-09-26 RU RU2018109295A patent/RU2765072C2/ru active
- 2013-09-26 RS RS20210825A patent/RS62075B1/sr unknown
- 2013-09-26 PL PL13774881T patent/PL2900676T3/pl unknown
- 2013-09-26 PT PT13774881T patent/PT2900676T/pt unknown
- 2013-09-26 JP JP2015534641A patent/JP6517693B2/ja active Active
- 2013-09-26 SI SI201331374T patent/SI2900676T1/sl unknown
- 2013-09-26 SI SI201331899T patent/SI3486248T1/sl unknown
- 2013-09-26 ES ES13774881T patent/ES2716561T3/es active Active
- 2013-09-26 RS RS20190314A patent/RS58493B1/sr unknown
- 2013-09-26 WO PCT/US2013/061839 patent/WO2014052537A1/en not_active Ceased
- 2013-09-26 DK DK18213678.8T patent/DK3486248T3/da active
- 2013-09-26 BR BR112015006505-8A patent/BR112015006505B1/pt active IP Right Grant
- 2013-09-26 EP EP18213678.8A patent/EP3486248B1/en active Active
- 2013-09-26 LT LTEP18213678.8T patent/LT3486248T/lt unknown
- 2013-09-26 SG SG11201501918UA patent/SG11201501918UA/en unknown
- 2013-09-26 SM SM20190170T patent/SMT201900170T1/it unknown
- 2013-09-26 CN CN201810251853.0A patent/CN108586487B/zh active Active
- 2013-09-26 MX MX2015003745A patent/MX366701B/es active IP Right Grant
- 2013-09-26 RU RU2015111635A patent/RU2648992C2/ru active
- 2013-09-26 MX MX2019008652A patent/MX390615B/es unknown
- 2013-09-26 PL PL18213678T patent/PL3486248T3/pl unknown
- 2013-09-26 HR HRP20190473TT patent/HRP20190473T1/hr unknown
- 2013-09-26 EP EP13774881.0A patent/EP2900676B1/en active Active
-
2015
- 2015-03-17 US US14/660,050 patent/US9469655B2/en active Active
- 2015-03-19 ZA ZA2015/01898A patent/ZA201501898B/en unknown
- 2015-03-23 IL IL237899A patent/IL237899A/en active IP Right Grant
-
2016
- 2016-09-19 US US15/269,163 patent/US9796731B2/en active Active
-
2017
- 2017-08-14 IL IL253988A patent/IL253988B/en active IP Right Grant
- 2017-09-19 US US15/708,346 patent/US10100062B2/en active Active
-
2018
- 2018-02-27 JP JP2018032684A patent/JP2018109044A/ja not_active Ceased
- 2018-02-27 AU AU2018201392A patent/AU2018201392B2/en active Active
- 2018-09-12 US US16/129,268 patent/US10461449B2/en active Active
-
2019
- 2019-03-13 CY CY20191100302T patent/CY1121415T1/el unknown
- 2019-09-18 US US16/574,718 patent/US10944190B2/en active Active
-
2020
- 2020-04-06 JP JP2020068137A patent/JP6735000B1/ja active Active
- 2020-06-10 AU AU2020203823A patent/AU2020203823B2/en active Active
- 2020-07-10 JP JP2020118929A patent/JP2020180150A/ja active Pending
-
2021
- 2021-06-29 HR HRP20211030TT patent/HRP20211030T1/hr unknown
- 2021-07-02 CY CY20211100594T patent/CY1124337T1/el unknown
-
2022
- 2022-02-28 JP JP2022029253A patent/JP2022068367A/ja active Pending
- 2022-03-07 AU AU2022201557A patent/AU2022201557A1/en not_active Abandoned
-
2023
- 2023-09-05 US US18/242,321 patent/US20240145953A1/en not_active Abandoned
- 2023-10-23 JP JP2023181529A patent/JP2024010055A/ja active Pending
-
2024
- 2024-01-19 US US18/417,406 patent/US20240313444A1/en not_active Abandoned
- 2024-05-31 US US18/679,863 patent/US20250007192A1/en active Pending
-
2025
- 2025-03-31 JP JP2025058629A patent/JP2025098242A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ706019A (en) | Improved methods for the acylation of maytansinol | |
| PH12015500040A1 (en) | Supercritical hydrolysis of biomass | |
| IN2012KN02804A (enExample) | ||
| MX2015007645A (es) | Cyanobacterium sp. para produccion de compuestos. | |
| MX2015002487A (es) | Proceso para la preparacion de teneligliptina. | |
| MX2011013112A (es) | Solventes novedosos para la produccion de dispersiones de poliuretano. | |
| GB2509659A (en) | Process for preparing buprenorphine | |
| EA201500234A1 (ru) | Способ получения бензоксазинонов | |
| IN2014DN09053A (enExample) | ||
| MX2014014138A (es) | Procedimiento nuevo para la preparacion de acido 2-ciclopentil-6-metoxi-isonicotinico. | |
| MX2015013589A (es) | Proceso e intermediario para la preparacion de pregabalina. | |
| MY184391A (en) | Microorganism having improved intracellular energy level and method for producing l-amino acid using same | |
| IN2013MU01431A (enExample) | ||
| PH12016501704B1 (en) | Method for producing 2-acyliminopyridine derivative | |
| SG10201806671UA (en) | Methoxycarbonylation with formic acid as co source | |
| IN2014DN07656A (enExample) | ||
| MX349985B (es) | Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi. | |
| LT2012082A (lt) | Nauji fotochrominiai junginiai, jų gamybos būdas ir tarpiniai junginiai jiems gauti | |
| EA201300650A1 (ru) | Разделение энантиомеров производных триазина с использованием винной кислоты | |
| IN2015DN01969A (enExample) | ||
| MX2015009565A (es) | Proceso para elaborar derivados de magnolol. | |
| PH12017500220A1 (en) | Method for obtaining crystalline l-alanine | |
| MX2017003498A (es) | Sal de ester metilico de fenilglicina. | |
| MX361888B (es) | Un procedimiento mejorado para producir zilpaterol. | |
| MX364769B (es) | Proceso para producir 2-fenil-1, 3-benzoxazoles. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2019 BY COMPUTER PACKAGES INC Effective date: 20180831 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2020 BY COMPUTER PACKAGES INC Effective date: 20190831 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2021 BY COMPUTER PACKAGES INC Effective date: 20200901 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2022 BY COMPUTER PACKAGES INC Effective date: 20210830 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2023 BY COMPUTER PACKAGES INC Effective date: 20220830 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2024 BY COMPUTER PACKAGES INC Effective date: 20230830 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2025 BY COMPUTER PACKAGES INC Effective date: 20240830 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 26 SEP 2026 BY THOMSON REUTERS Effective date: 20250801 |